Published: Feb 2, 2018, 10:43 am • Updated: Feb 2, 2018, 10:56 am
As Canada’s stock exchanges and securities regulators grow increasingly concerned about the state of legal cannabs south of the border, a Canadian medical marijuana company has started to divest its U.S.-based cannabis investments and assets.
Officials for Aphria (TSX: APH, OTCQB: APHQF) disclosed the move in a one-sentence announcement released Thursday morning:
“Aphria Inc. confirms today that the company is currently exploring and considering strategic alternatives with respect to its U.S. cannabis-related interests, including the possible divestiture of its investments to strategic, long-term and committed investors in the cannabis industry,” officials wrote in the announcement.
Aphria officials told The Cannabist that they have no further comments at this time and will provide more information as events warrant.
On Friday, Aphria made its first move: The firm sold its minority holdings in Arizona-based Copperstate Farms LLC to industry investor Liberty Health Sciences Inc. for $20 million CAD ($16.4 million USD).
Aphria has made investments in marijuana dispensary and cultivation operations